Determining the costs of families' support networks following a child's cancer diagnosis.

Search TravelDoctorOnline

Authors: Tsimicalis A,Stevens B,Ungar WJ,Greenberg M,McKeever P,Agha M,Guerriere D,Barr R,Naqvi A,Moineddin R,
Address: School of Nursing, Columbia University, New York, NY 10032, USA. at2704@columbia.edu
Journal: Cancer Nurs.


Publication: 2013 Mar;36(2):E8-E19. doi: 10.1097/NCC.0b013e3182551562.

abstract

BACKGROUND:

cancer in children may place considerable economic burden on more than individual family members. the costs incurred to families' support networks (FSNs) have not been previously studied.

OBJECTIVES:

The study objectives were to (a) identify and determine independent predictors of the direct and time costs incurred by the FSN and (b) explore the impact of these cancer-related costs on the FSN.

METHODS:

A prospective mixed-methods study was conducted. Representing the FSN, parents recorded the resources consumed and costs incurred during 1 week per month for 3 consecutive months, beginning 1 month following their child's diagnosis. Descriptive statistics, multiple regression modeling, and descriptive qualitative analytical methods were used to analyze the data.

RESULTS:

In total, 28 fathers and 71 mothers participated. The median total direct and time costs for the 3 months were CAN$154 and $2776, respectively, per FSN. The largest component of direct and time costs was travel and foregone leisure. Direct and time costs were greatest among those parents who identified a support network at baseline. Parents relied on their FSN to "hold the fort," which entailed providing financial support, assuming household chores, maintaining the siblings' routines, and providing cancer-related care.

CONCLUSIONS:

Families' support networks are confronted with a wide range of direct and time costs, the largest being travel and foregone leisure.

IMPLICATIONS FOR PRACTICE:

Families' support networks play an important role in mitigating the effects of families' costs. Careful screening of families without an FSN is needed.



Related Articles
A prospective study to determine the costs incurred by families of children newly diagnosed with cancer in Ontario.
Psychooncology. 2012
A prospective study to determine the costs incurred by families of children newly diagnosed with cancer in Ontario.
Tsimicalis A, Stevens B, Ungar WJ, McKeever P, Greenberg M, Agha M, Guerriere D, Barr R, Naqvi A, Moineddin R. Psychooncology. 2012 Oct; 21(10):1113-23. Epub 2011 Jul 20.
A mixed method approach to describe the out-of-pocket expenses incurred by families of children with cancer.
Pediatr Blood Cancer. 2013
A mixed method approach to describe the out-of-pocket expenses incurred by families of children with cancer.
Tsimicalis A, Stevens B, Ungar WJ, McKeever P, Greenberg M, Agha M, Guerriere D, Naqvi A, Barr R. Pediatr Blood Cancer. 2013 Mar; 60(3):438-45. Epub 2012 Sep 26.
Family pediatrics: report of the Task Force on the Family.
Pediatrics. 2003
Family pediatrics: report of the Task Force on the Family.
Schor EL, American Academy of Pediatrics Task Force on the Family. Pediatrics. 2003 Jun; 111(6 Pt 2):1541-71.
Review A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Health Technol Assess. 2001
Review A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N. Health Technol Assess. 2001; 5(32):1-195.
Review [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Encephale. 2005
Review [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, et al. Encephale. 2005 Mar-Apr; 31(2):235-46.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.